SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001213900-22-073450 from Lichen China Ltd (LICN) (CIK 0001876766) (LICN)

Lichen China Ltd (LICN) (CIK 0001876766)
Date: Nov. 17, 2022 · CIK: 0001876766 · Accession: 0001213900-22-073450

AI Filing Summary & Sentiment

File numbers found in text: 333-264624

Referenced dates: October 26, 2022

Date
November 17, 2022
Author
/s/ Ya Li
Form
CORRESP
Company
Lichen China Ltd (LICN) (CIK 0001876766)

Letter

Via EDGAR Correspondence Division of Corporation Finance Office of Trade & Services Lichen China Ltd. Amendment No. 4 to Registration Statement on Form F-1 Filed October 7, 2022 File No. 333-264624

Dear Ms. Wall,

This letter is in response to the letter dated October 26, 2022, from the staff (the “Staff”) of the U.S. Securities and Exchange Commission (the “Commission”) addressed to Lichen China Ltd. (the “Company”, “we”, and “our”). For ease of reference, we have recited the Commission’s comments in this response and numbered them accordingly. An amended registration statement on Form F-1 (the “Amended Registration Statement”) is being filed to accompany this letter.

Amendment No. 4 to Registration Statement on Form F-1

Dilution, page 61

1. We note your disclosure of net tangible book value attributable to shareholders on June 30, 2022 of approximately $1.57 per ordinary share appears to be inconsistent with the amount of total assets ($44,538,000) less intangible assets ($5,808,000) and total liabilities ($5,434,000), divided by the number of total ordinary shares outstanding (22,500,000) at June 30, 2022. Please clarify or revise.

RESPONSE: We note the Staff’s comment, and in response thereto, respectfully advise the Staff that we have revised the Dilution section of the Amended Registration Statement to reflect the correct numbers.

We hope this response has addressed all of the Staff’s concerns relating to the comment letter. Should you have additional questions regarding the information contained herein, please contact our outside securities counsel William S. Rosenstadt, Esq. or Mengyi “Jason” Ye, Esq. of Ortoli Rosenstadt LLP at wsr@orllp.legal or jye@orllp.legal.

Very truly yours,
/s/ Ya Li

Show Raw Text
CORRESP
1
filename1.htm

Lichen China Ltd.

B2306, Block B

Tower 3, Jinjiang Wanda Plaza Commercial Complex

888 Century Avenue

Meiling Street, Jinjiang

Fujian Province, People’s Republic of China
362000

November 17, 2022

Via EDGAR Correspondence

Ms. Alyssa Wall

Division of Corporation Finance

Office of Trade & Services

U.S. Securities and Exchange Commission

100 F Street, NE

Washington, D.C., 20549

    Re:

    Lichen China Ltd.

    Amendment No. 4 to Registration Statement on Form F-1

    Filed October 7, 2022

    File No. 333-264624

Dear Ms. Wall,

This letter is in response to the letter dated
October 26, 2022, from the staff (the “Staff”) of the U.S. Securities and Exchange Commission (the “Commission”)
addressed to Lichen China Ltd. (the “Company”, “we”, and “our”). For ease of reference, we have recited
the Commission’s comments in this response and numbered them accordingly. An amended registration statement on Form F-1 (the “Amended
Registration Statement”) is being filed to accompany this letter.

Amendment No. 4 to Registration Statement on
Form F-1

Dilution, page 61

1. We note your disclosure of net tangible
book value attributable to shareholders on June 30, 2022 of approximately $1.57 per ordinary share appears to be inconsistent with the
amount of total assets ($44,538,000) less intangible assets ($5,808,000) and total liabilities ($5,434,000), divided by the number of
total ordinary shares outstanding (22,500,000) at June 30, 2022. Please clarify or revise.

RESPONSE: We note the Staff’s comment,
and in response thereto, respectfully advise the Staff that we have revised the Dilution section of the Amended Registration Statement
to reflect the correct numbers.

We hope this response has addressed all of the
Staff’s concerns relating to the comment letter. Should you have additional questions regarding the information contained herein,
please contact our outside securities counsel William S. Rosenstadt, Esq. or Mengyi “Jason” Ye, Esq. of Ortoli Rosenstadt
LLP at wsr@orllp.legal or jye@orllp.legal.

    Very truly yours,

    /s/ Ya Li

    Name:
    Ya Li

    Title:
    Chief Executive Officer and Director